BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 31

• Eribis Pharmaceuticals Receives Investment for Clinical Development of Novel Cardiovascular Therapy

  January 26, 2010

   · 

  2 min read
• Business

  3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010

  January 26, 2010

   · 

  1 min read
• Pharm Country

  Neurologix, Inc. Gains Broadened U.S. Patent Protection for Its GAD-Based Gene Delivery System

  January 26, 2010

   · 

  1 min read
• Business

  OncoVista Innovative Therapies, Inc. Subsidiary AdnaGen Inks Exclusive Agreement with TATAA Molecular Diagnostics

  January 26, 2010

   · 

  1 min read
• Drug Development

  ResearchPoint & Azaya Therapeutics, Inc. Announce First Patient Enrolled in Phase I Clinical Study

  January 26, 2010

   · 

  1 min read
• Business

  Tripos Licenses Benchware Discovery 360 to Pfizer Inc.

  January 26, 2010

   · 

  1 min read
• Business

  Waters Corporation Reports Fourth Quarter 2009 Financial Results

  January 26, 2010

   · 

  1 min read
• Drug Development

  Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma

  January 26, 2010

   · 

  1 min read
• Pharm Country

  ZIOPHARM Oncology, Inc. Receives Important Palifosfamide U.S. Patent Allowance

  January 26, 2010

   · 

  1 min read
• Business

  Array BioPharma, Inc. to Report Financial Results for the Second Quarter of Fiscal 2010 on February 1, 2010

  January 26, 2010

   · 

  1 min read